Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-24T05:35:38.472Z Has data issue: false hasContentIssue false

Gore Cardioform atrial septal occluder: deployment procedure and techniques for closing challenging secundum atrial septal defects

Published online by Cambridge University Press:  08 October 2021

Varun Aggarwal*
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA
Arjun K. Mohan
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA
John Bass
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA
Julia Steinberger
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA
Sameh M. Said
Affiliation:
Division of Pediatric Cardiac Surgery, Department of Surgery, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA
Athar M. Qureshi
Affiliation:
Lillie Frank Abercombie Section of Pediatric Cardiology, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA
*
Author for correspondence: V. Aggarwal, MD, Assistant Professor, Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, USA. Fax: +1-808-353-8011. Email: [email protected]

Abstract

Ostium secundum atrial septal defects are mostly closed in the cardiac catheterisation laboratories using either Amplatzer® (Abbott Laboratories, IL) atrial septal occluder, Gore® Cardioform septal occluder and more recently using the recently approved (US FDA approval June 2019) Gore® Cardioform atrial septal defect occluder (W. L. Gore & Associates, AZ). Similar to any new device in the market, there is a learning curve to the deployment of this device. We therefore aim to report the key features about this new Gore Cardioform atrial septal defect occluder device with special emphasis on technical aspects that can be employed during transcatheter closure of challenging ostium secundum atrial septal defects using this device.

Type
Review
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 18901900.10.1016/S0735-1097(02)01886-7CrossRefGoogle ScholarPubMed
Kirklin, JW, Barratt-Boyes, BG. Cardiac Surgery. John Wiley & Sons, New York, NY, 1986.Google Scholar
King, TD, Mills, NL. Nonoperative closure of atrial septal defects. Surgery 1974; 75: 383388.Google ScholarPubMed
Kaulitz, R, Peuster, M, Jux, C, Paul, T, Hausdorf, G. Transcatheter closure of various types of defects within the oval fossa using the double umbrella device (CardioSEAL)--feasibility and echocardiographic follow-up. Cardiol Young 2001; 11: 214222.10.1017/S1047951101000142CrossRefGoogle ScholarPubMed
O'Laughlin, MP. Catheter closure of secundum atrial septal defects. Tex Heart Inst J 1997; 24: 287292.Google ScholarPubMed
Rao, PS, Berger, F, Rey, C, et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J Am Coll Cardiol 2000; 36: 583592.CrossRefGoogle ScholarPubMed
Hoehn, R, Hesse, C, Ince, H, Peuster, M. First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease. Catheter Cardiovasc Interv 2010; 75: 7277.Google ScholarPubMed
Turner, DR, Owada, CY, Sang, CJ, Khan, M, Lim, DS. Closure of secundum atrial septal defects with the AMPLATZER Septal Occluder: a prospective, multicenter, post-approval study. Circ Cardiovasc Interv 2017; 10: E592.CrossRefGoogle ScholarPubMed
Latson, LA, Zahn, EM, Wilson, N. Helex septal occluder for closure of atrial septal defects. Curr Interv Cardiol Rep 2000; 2: 268273.Google ScholarPubMed
Gillespie, MJ, Javois, AJ, Moore, P, Forbes, T, Paolillo, JA, GSO Investigator Group. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: results of the multicenter U.S. IDE trial. Catheter Cardiovasc Interv 2020; 95: 12961304.CrossRefGoogle ScholarPubMed
Sommer, RJ, Love, BA, Paolillo, JA, et al. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2020; 95: 12851295.10.1002/ccd.28728CrossRefGoogle ScholarPubMed
Kumar, P, Orford, JL, Tobis, JM. Two cases of pericardial tamponade due to nitinol wire fracture of a gore septal occluder. Catheter Cardiovasc Interv 2020; 96: 219224.10.1002/ccd.28596CrossRefGoogle ScholarPubMed
Eilers, LF, Gowda, ST, Gowda, S, et al. Mullins TM sheath facilitated delivery of Gore Cardioform ASD Occluder Devices for closure of large or challenging secundum atrial septal defects. J Invasive Cardiol 2021; 33: E425E430.Google ScholarPubMed
Bartakian, S, El-Said, HG, Printz, B, Moore, JW. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder. JACC Cardiovasc Interv 2013; 6: 974980.CrossRefGoogle ScholarPubMed